Related Experiment Video
Updated: Feb 18, 2026

11:17
A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
Published on: August 11, 2018
12.6K
Pattern and predictors of paradoxical response in patients with peripheral lymph node tuberculosis
Supreet Batra1, Govind Singh Rajawat2, Rajendra Prasad Takhar3
1Department of Respiratory Medicine, V P Chest Institute, Delhi, India.
Tuberkuloz Ve Toraks
|November 15, 2017
Summary
Paradoxical response in peripheral lymph node tuberculosis (TB) occurs in a quarter of patients, often presenting as enlarged or new lymph nodes. Younger age, female gender, unilateral lymphadenopathy, and positive AFB tests predict this response.
Area of Science:
- Infectious Diseases
- Immunology
- Public Health
Background:
- Peripheral lymph node tuberculosis (TB) can manifest paradoxical responses (PR) during treatment, including new or enlarged lymph nodes and worsening disease.
- The underlying predictors for PR in selective patients remain unclear, necessitating further investigation.
Purpose of the Study:
- To evaluate the pattern and identify predictors of paradoxical responses (PR) in patients with peripheral lymph node tuberculosis (TB).
Main Methods:
- A study included 110 patients over 6 years old with peripheral lymphadenopathy of tubercular etiology.
- Paradoxical response was defined as worsening of pre-existing disease or new lesions after at least 2 weeks of anti-TB therapy.
Main Results:
- Paradoxical response (PR) occurred in 25% of patients, with a mean onset of 6 weeks after starting anti-TB medication.
- PR was more frequent in younger patients, females, those with unilateral lymphadenopathy, and those with positive acid-fast bacilli (AFB) on initial examination (p<0.01).
- Common presentations of PR included enlarged lymph nodes (79%), new nodes (29%), and discharging sinuses (7%).
Conclusions:
- Paradoxical response in peripheral lymph node TB is associated with younger age, female gender, unilateral lymphadenopathy, and positive AFB smears at diagnosis.
- These findings can aid in identifying patients at higher risk for PR and tailoring management strategies.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
557
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
557
Pulmonary Tuberculosis III
1.1K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.1K
Pulmonary Tuberculosis II
1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
Pulmonary Tuberculosis V
656
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
656
Pulmonary Tuberculosis I
1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K

